Current status and future challenges in cerebral blood flow mapping in intracranial tumors

Keio Journal of Medicine

Volumn 49, Issue SUPPL. 1, 2000, Pages

  Mirzai, Shahram ^a   Samii, Madjid ^a  

^a NORDSTADT HOSPITAL   (Germany)

Author keywords

CBF; Edema; Functional mapping; Glioma; Meningioma; Tumor; XenonCT

Indexed keywords

XENON;

BRAIN BLOOD FLOW; BRAIN MAPPING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC VALUE; GLIOMA; HUMAN; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MENINGIOMA;

ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; GLIOMA; HUMANS; MENINGIOMA; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; XENON;

EID: 0034074585     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Nagashima T, Tamura A, Matsutani M, et al: Regional CBF in experimental brain tumors, Comparative study between blood flow and neuropathological characteristics. J CBF & Metabol 1983; 3 Suppl 1: 69-70
2. Baba T, Fukui M, Sakata S, et al: Selective enhancement of intratumoral blood flow in malignant gliomas, experimental study in rats by intracarotid administration of adenosine or adenosine triphosphate. Acta Neurochirurg 1989; 101: 66-74
3. Aizawa S, Sako K, Yonemasu Y: Measurement of cerebral blood flow, cerebral blood volume, and cerebral capillary permeability in glioma-bearing rats. Neurol Med Chir 1990; 30: 113-118
4. Endo H, Larsen B, Lassen NA: RCBF alterations remote from the site of intracranial tumors. J Neurosurg 1977; 46: 271-281
5. Di Chiro G, DeLaPaz RL, Brooks RA, et al: Glucose utilization of cerebral gliomas measured by [F18] fluorodeoxyglucose and PET. Neurology 1982; 32: 1323-1329
6. Nakamura O, Segawa H, Tanaka H, et al: Regional CBF in brain tumours as measured by xenon enhanced CT. Neurol Res 1987; 9: 24-29
7. Nakano S, Kinoshita K, Jinnouchi S, et al: Dynamic SPECT with iodine-123 IMP in meningiomas. J Nucl Med 1988; 29: 1627-1632
8. Mirzai S, Samii M: Assessment of patients with intracranial mass lesions: Tumors. In: Tomonaga M, Tanaka A, Yonas H, eds, Quantitative Cerebral Blood Flow Measurements Using Stable Xenon/CT, NY, Futura, 1995; 251-263
9. Namba H, Yanagisawa M, Yui N, et al: Quantifying brain tumor blood flow by the microsphere model with N-IMP SPECT. Ann Nucl Med 1996; 10: 161-164
10. Kaschten B, Stevenaert A, Sadzot B, et al: Preoperative evaluation of 54 gliomas by PET with Fluorine-18-FDG and/or C-11-Methionine. J Nucl Med 1998; 39: 778-785
11. Beaney RP, Brooks DJ, Leenders KL, et al: Blood flow and oxygen utilization in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by PET, with observations on the effect of decompressive surgery. J Neurol Neurosurg Psychiat 1985; 48: 310-319
12. Cronqvist S, Agee F: Regional CBF in intracranial tumours. Acta Radiol 1968; 7: 393-404
13. Palvölgyi R: Regional CBF in patients with intracranial tumors. J Neurosurg 1969; 31: 149-162
14. Blasberg RG, Molnar P, Horowitz M, et al: Regional blood flow in RT-9 brain tumors. J Neurosurg 1983; 58: 863-873
15. Groothuis DR, Pasternak JF, Fischer JM, et al: Regional measurements of blood flow in experimental RG-2 rat gliomas. Cancer Res 1983; 43: 3362-3367
16. Graham MM, Spence AM, Abbott GL, et al: Blood flow in an experimental rat brain tumor by tissue equilibration and indicator fractination. J Neurooncology 1987; 5: 37-43
17. Baba T, Fukui M, Takeshita I, et al: Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate. J Neurosurg 1990; 72: 907-911
18. Tatagiba M, Mirzai S, Samii M: Peritumoral Blood Flow in Intracranial Meningiomas. Neurosurgery 1991; 28: 400-404
19. Mirzai S, Tatagiba M, Böker DK, Samii M: Cerebral and Tumor Blood Flow in Intracranial Tumors. Adv Neurosurgery 1994; 22: 198-206
20. Toglia A, Kittelson JM, Roemer RB, et al: Cerebral blood flow in and around spontaneous malignant gliomas. Hyperthermia 1996; 12: 461-476
21. Roessler K, Nasel C, Czech T, et al: Histological heterogeneity of neuroradiologically suspected adult low grade gliomas detected by xenon-enhanced CT. Acta Neurochir 1996; 138: 1341-1347
22. Nakagawa T, Tanaka R, Takeuchi S, Takeda N: Haemodynamic evaluation of cerebral gliomas using XeCT. Acta Neurochir 1998; 140: 223-234
23. Lammertsma AA, Wise RJS, Cox TC, et al: Measurement of blood flow, oxygen utilization, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br J Radiology 1985; 58: 725-734
24. Mineura K, Yasuda T, Kowada M, et al: PET evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 1986; 8: 164-168
25. Tyler JL, Diksic M, Villemure JG, et al: Metabolic and hemodynamic evaluation of gliomas using PET. J Nucl Med 1987; 28, 1123-1133
26. Shinoura N, Nishijima M, Hara T, et al: Brain tumors: Detection with C-11 Choline PET. Radiology 1997; 202: 497-503
27. Roelcke U, Blasberg RG, von Ammon K, et al: Dexamethasone treatment and plasma glucose levels: Relevance for Fluorine-18-FDG uptake measurements in gliomas. J Nucl Med 1998; 39: 879-884
28. Hirnao T, Otake U, Kazama K, et al: Technetium-99m-DMSA and Thallium-201 in brain tumor imaging. J Nucl Med 1997; 38: 1741-1749
29. Young IR, Hall AS, Bryant DJ, et al: Assessment of brain perfusion with MR imaging. J CAT 1988; 12: 721-727
30. Langen KJ, Herzog H, Kuwert T, et al: Tomographic studies of rCBF with 99mTc-HMPAO SPECT in patients with brain tumors, Comparison with C15O2 continous inhalation technique and PET. J CBF and Metabol 1988; 8: 90-94
31. Weber W, Bartenstein P, Gross MW, et al: Fluorine-18-FDG PET and Iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 1997; 38: 802-808
32. Boeck JC, Sander B, Hierholzer J, et al: Regionale Durchblutung bei intrakraniellen Tumoren, Vergleich der HMPAO-SPECT mit einem neueren magnetresonanztomographischen Verfahren. RöFo 1992; 157: 378-383
33. Di Chiro G, Hatazawa J, Katz DA, et al: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence, A PET study. Radiology 1987; 164: 521-526
34. Hylton PD, Reichman H, Palutsis R: Monitoring of transient central nervous system postirradiation effects by 133 Xe inhalation rCBF measurements. Neurosurgery 1987; 21: 843-848
35. Yonas H, Gur D, Latchaw R, Wolfson SK Jr.: Stable xenon CT/CBF imaging: laboratory and clinical experience. Adv Techn Stand Neurosurg 1987; 15: 1-37
36. Yonas H, Sekhar L, Johnson DW, Gur D: Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 1989; 24: 368-372
37. Hughes RL, Yonas H, Gur D, Latchaw R: Cerebral blood flow determination within the first 8 hours of cerebral infarction using stable xenon-enhanced computed tomography. Stroke 1989; 20: 754-760
38. Ito M, Lammertsma AA, Wise RJS, et al: Measurement of rCBF and oxygen utilization in patients with cerebral tumours using 150 and PET, analytical techniques and preliminary results. Neuroradiology 1982; 23: 63-74
39. Hino A, Imahori Y, Tenjin H, et al: Metabolic and hemodynarnic aspects of peritumoral low-density areas in human brain tumor. Neurosurgery 1990; 26: 615-621
40. Lammertsma AA, Wise RJS, Jones T: RCBF and Oxygen utilization in edema associated with cerebral tumors. In: Go KG, Baethmann A, eds, Recent Progress in the study and Therapy of Brain Edema, NY, Plenum, 1984; 331-44
41. Trittmacher S, Traupe H, Schmid A: Pre-and postoperative changes in brain tissue surrounding a meningioma. Neurosurgery 1988; 22: 882-885
42. Erba SM, Horton JA, Latchaw RE, et al: Balloon test occlusion of the internal carotid artery with stable xenon/CT CBF imaging. AJNR 1988; 9: 533-538
43. De Vries EJ, Sekhar LN, Horton JA, et al: A new method to predict safe resection of the internal carotid artery. Laryngoscope 1990; 100: 85-88
44. Matsuda H, Higashi S, Asli IN, et al: Evaluation of cerebral collateral circulation by Tc-99m HMPAO brain SPECT during Matas test, report of three cases. J Nucl Med 1988; 29: 1724-1729
45. Simonson TM, Ryals TJ, Yuh WT, et al: MR imaging and HMPAO scintigraphy in conjunction with balloon test occlusion, value in predicting sequelae after permanent carotid occlusion. AJR 1992; 159: 1063-1069
46. Yamamoto S, Sunada I, Akano Y, Hakuba A: Preoperative balloon occlusion test for cranial base surgery with single photon emission CT. In: Samii M, ed, Skull Base Surgery, Basel. Karger 1994:454-457
47. Sen C, Sekhar LN: Direct vein graft reconstruction of the cavernous, petrous, and upper cervical internal carotid artery: lessons learned from 30 cases. Neurosurgery 1992; 30: 732-43
48. Okudaira Y, Arai H, Sato K: Cerebral blood flow alteration by acetazolamide during carotid balloon occlusion. Stroke 1996; 27: 617-621
49. Takasago T, Yamashita T, Hayashi M, et al: The acetazolamide-loading Matas test as a preoperative test for patients with internal carotid cavernous giant aneurysms. In: Tomonaga M, Tanaka A, Yonas H, eds. Quantitative Cerebral Blood Flow Measurements Using Stable Xenon/CT. NY, Futura. 1995: 215-219
50. Broich K, Hartmann A, Biersack HJ, et al: Crossed cerebello-cerebral diaschisis in a patient with cerebellar infarction. Neurosci Lett 1987; 83: 7-12